Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Clinical Rheumatology|September 3, 2020
Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritisGerd Burmester, Edit Drescher, Pawel Hrycaj, et al.
Clinical Pharmacology in Drug Development|July 7, 2020
A Randomized, Double-Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid ArthritisGerd Burmester, David Chien, Vincent Chow, et al.
Analytical Cellular Pathology (Amsterdam)|November 3, 2011
Localization of ORC1 during the cell cycle in human leukemia cellsFrederick D Coffman, Mai-Ling Reyes, Monique Brown, et al.
Arthritis and Rheumatism|March 29, 2002
A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis siccaDianne Petrone, John J Condemi, Rose Fife, et al.
Audiology & Neuro-Otology|October 29, 2010
A pilot study of rituximab in immune-mediated inner ear diseaseStanley Cohen, Peter Roland, Angela Shoup, et al.
Clinical Therapeutics|April 27, 2016
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic LupusStanley Cohen, Megan Clowse, Patricia Pardo, et al.
Cytokine|July 16, 2014
MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cellsCrystal J DiCosmo-Ponticello, Daniel Hoover, Frederick D Coffman, et al.
Transplantation|July 20, 2002
Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patientsHelen Fernandes, Baburao Koneru, Neil Fernandes, et al.
Arthritis and Rheumatism|May 18, 2004
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexateMark C Genovese, Stanley Cohen, Larry Moreland, et al.
Rheumatology and Therapy|February 23, 2018
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid ArthritisStanley Cohen, Jeffrey R Curtis, Ryan DeMasi, et al.
Pageof 11